Table 2.
Author | Year of publication | Cases | Stage | Maximum AFP level (ng/ml) | Etiology | Additional Treatment | Follow up |
---|---|---|---|---|---|---|---|
Norgaard-Pedersen et al. [33] | 1984 | 3 | NA | 30 | NA | – | ANED |
Germ et al. [34] | 1986 | 2 | IV | 169 | HD | – | ANED |
Germa et al. [26] | 1993 | 1 | II | 36 | HD | – | ANED |
Nazeer et al. [37] | 1998 | 10 | NA | 16 | NA | Yes (n = 5) | ANED |
Morris et al. [35] | 2000 | 1 | I | 20 | NA | – | ANED |
Funahashi et al. [31] | 2005 | 1 | I | 40 | HD | – | ANED |
Vazeille et al. [36] | 2016 | 1 | I | 19 | NA | – | ANED |
Wymer et al. [18] | 2017 | 4 | I | 40.2 | NA | – | ANED |
Dieckmann et al. [32] | 2017 | 5 | I: 3, II: 1, R: 1 | 20.4 | NA | Yes (n = 1) | ANED |
ANED Alive with no evidence of disease, HD Hepatic dysfunction, R Relapse, NA Not available